Patents Examined by Amy M Bunker
  • Patent number: 11932847
    Abstract: Disclosed is a method of fragmenting DNA comprising contacting a sample of target DNA with (a) a composition comprising an active transpososome, and (b) a composition comprising an inactive transpososome, under conditions suitable for transpososome activity, wherein a ratio of an amount of the inactive transpososome in the composition of (b) to an amount of the active transpososome in the composition of (a) determines the mean fragment size and a level of insertion bias.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: March 19, 2024
    Assignee: KAPA BIOSYSTEMS, INC.
    Inventors: Martin Ranik, Eric Van der Walt, William Bourn, Jennifer Hsieh, Abre De Beer, Gerrida Uys, Paul McEwan
  • Patent number: 11921110
    Abstract: A method for controlled production of an array of planar microparticles with the multiplexing of molecules on the surface thereof, intended to function as molecular sensors and/or actuators and a matrix (array) of microparticles, the surface thereof being printed with all of the molecular components required to provide the surface with functionality. Different molecular elements are multiplexed on the surface of each particle while they are supported on a substrate by means of a structural foot engraved below the particle. These microparticles can be released mechanically from the support on which they are produced using a controlled mechanical rupture method which is not chemically aggressive and therefore does not affect the molecules previously printed on the surface. The array and the particles contained therein offer great versatility in both chemical and/or biological applications.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: March 5, 2024
    Assignee: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC)
    Inventors: Jaume Esteve Tintó, José Antonio Plaza Plaza, Marta Duch Llobera, Núria Torras Andrés, María Luisa Pérez García, Juan Pablo Agusil Antonoff
  • Patent number: 11899020
    Abstract: This invention provides methods for the screening and identification of antigenic components in a tissue or organ of interest.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: February 13, 2024
    Assignee: The Regents of the University of California
    Inventors: Leigh G. Griffiths, Katherine Y. Gates, Ailsa J. Dalgliesh, Maelene L. Wong
  • Patent number: 11873480
    Abstract: Embodiments provided herein relate to methods and compositions for preparing an immobilized library of barcoded DNA fragments of a target nucleic acid, identifying genomic variants, determining the contiguity information, phasing information, and methylation status of the target nucleic acid.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: January 16, 2024
    Assignee: ILLUMINA CAMBRIDGE LIMITED
    Inventors: Frank J. Steemers, Kevin L. Gunderson, Fan Zhang, Jason Richard Betley, Niall Anthony Gormley, Wouter Meuleman, Jacqueline Weir, Avgousta Ioannou, Gareth Jenkins, Rosamond Jackson, Natalie Morrell, Dmitry K. Pokholok, Steven J. Norberg, Molly He, Amirali Kia, Igor Goryshin, Rigo Pantoja
  • Patent number: 11795580
    Abstract: The present disclosure relates to multifunctional verification molecules, including molecules according to formula (I): G-L-(B)K-Q-U, wherein G, L, B, K, Q, and U are defined herein. The present disclosure also relates to methods of preparing and using such multifunctional verification molecules to remove defective multifunctional molecules and to quantify synthetic yield.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: October 24, 2023
    Assignee: Haystack Sciences Corporation
    Inventors: Richard Edward Watts, Divya Kanichar
  • Patent number: 11785922
    Abstract: Provided are a protein complex in which estrogen receptor 2 (-ERT2) is fused to CRISPR associated protein 9 (Cas9), and a recombinant vector carrying a gene coding the protein complex, wherein ERT2 is bonded to the N-terminus and C-terminus of nuclear localization sequence (NLS)-removed Cas9 and the complex has the advantage of translocating from the cytosol into the nucleus at a certain time point upon treatment with tamoxifen and modifying a specific DNA with the aid of guide RNA (gRNA), ultimately enabling a more elaborate DNA modification operation in a desired part at a desired time point.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: October 17, 2023
    Assignee: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Eun Ju Lee, Hyo-Soo Kim
  • Patent number: 11781133
    Abstract: Provided herein is a method for manufacturing a microarray system, for example, 3-dimensional lattice microarray system, for DNA sequence detection and analysis. A solid support, such as a plastic substrate, is contacted with a formulation containing a plurality of nucleic acid probes, a plurality of bifunctional polymer linkers, such as oligothymidine linkers, and a solvent mixture of water and a water-miscible liquid. The bifunctional polymer linkers are attached to the solid support and the water is evaporated. Then the nucleic acid probes are attached to the bifunctional polymer linker.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: October 10, 2023
    Assignee: PathogenDx, Inc.
    Inventors: Michael Edward Hogan, Melissa Rose May, Frederick Henry Eggers
  • Patent number: 11739322
    Abstract: Provided are an improved genome editing system and a method that has high specificity, which are capable of obtaining stable mutation types. The system includes an expression construct including a coding sequence of a gRNA targeting at least one genomic target sequence; an expression construct including a coding sequence of a CRISPR nuclease; and an expression construct including a coding sequence for a gRNA targeting a target sequence within the coding sequence of the CRISPR nuclease. Upon introduction into the cell, the gRNA targeting the at least one genomic target sequence directs the CRISPR nuclease to the at least one genomic target sequence and results in one or more mutations in the genomic target sequence, and the gRNA targeting a target sequence within the coding sequence of the CRISPR nuclease directs the CRISPR nuclease to the target sequence within the coding sequence of the CRISPR nuclease and results in an inactivating mutation of the CRISPR nuclease.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: August 29, 2023
    Assignee: INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Caixia Gao, Huawei Zhang, Shuai Jin
  • Patent number: 11738321
    Abstract: Disclosed herein are methods for tracking solutions, (e.g., reaction conditions in solutions). In some embodiments, the method comprises: contacting a first lanthanide-chelator complex to a first solution to generate a first barcoded solution, wherein the first lanthanide-chelator complex comprises a first lanthanide chelated by a first chelator; contacting a second lanthanide-chelator complex to a second solution to generate a second barcoded solution, wherein the second lanthanide-chelator complex comprises a second lanthanide chelated by a second chelator; mixing the first barcoded solution and the second barcoded solution to form one or more mixtures; and identifying the first lanthanide ions in the mass spectrum and the second lanthanide ions in the mass spectrum to track the condition of each of the one or more mixtures.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: August 29, 2023
    Assignees: The Regents of the University of California, National Technology & Engineering Solutions Of Sandia, LLC
    Inventors: Todd Duncombe, Trent R. Northen, Kai Deng, Anup K. Singh
  • Patent number: 11718849
    Abstract: The present invention relates to libraries of phosphopeptide-encoding oligonucleotides and methods of preparing such libraries. The present invention also relates to methods of detecting, visualizing, or screening for phosphorylation-dependent protein-protein interactions using recombinant phosphopeptides and/or phosphopeptide-encoding oligonucleotides. The present invention also relates to sets or kits of oligonucleotides having regions that encode phosphopeptides.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: August 8, 2023
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Jesse Rinehart, Karl Barber, Farren Isaacs, Jeffrey R Sampson
  • Patent number: 11697849
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: July 11, 2023
    Assignee: SEQUENOM, INC.
    Inventors: Cosmin Deciu, Mathias Ehrich, Dirk J. van den Boom, Zeljko Dzakula
  • Patent number: 11661597
    Abstract: A population of nucleic acid adaptors is provided. In some embodiments, the population contains at least 50,000 different molecular barcode sequences, where the barcode sequences are double-stranded and at least 90% of the barcode sequences have an edit distance of at least 2. In certain cases, the adaptor may have an end in which the top and bottom strands are not complementary (i.e., may be in the form of a Y-adaptor). In some embodiments and depending on the how the adaptor is going to be employed, the other end of the adaptor may have a ligatable end or may be a transposon end sequence.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: May 30, 2023
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Billy Tsz Cheong Lau, Hanlee P. Ji
  • Patent number: 11629131
    Abstract: The present invention relates to novel fluorophores and their use in combination with novel nucleic acid molecules, called aptamers, that bind specifically to the fluorophore and thereby enhance the fluorescence signal of the fluorophore upon exposure to radiation of suitable wavelength. Molecular complexes formed between the novel fluorophores, novel nucleic acid molecules, and their target molecules are described, and the use of multivalent aptamer constructs as fluorescent sensors for target molecules of interest are also described.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: April 18, 2023
    Assignee: CORNELL UNIVERSITY
    Inventors: Samie R. Jaffrey, Jeremy S. Paige
  • Patent number: 11584958
    Abstract: Aspects of the invention include methods for preparing sequencing libraries, performing sequencing procedures that can correct for process-related errors, and identifying rare variants that are or may be indicative of cancer.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: February 21, 2023
    Assignee: GRAIL, LLC
    Inventors: Arash Jamshidi, Gordon Cann, Hamed Amini, Alex Aravanis
  • Patent number: 11542498
    Abstract: Provided herein is a 3-dimensional lattice microarray system for DNA sequence detection and analysis. The system has a plurality of bifunctional polymer linkers, on one end of which are attached nucleic acid probes where each have a sequence complementary to signature nucleotide sequences in pathogens, plants or animals. The other end of the bifunctional polymer linker is attached to a solid support by non-covalent or covalent means. Each of the nucleic acid probes have terminal thymidine bases at the 5? and 3? ends that permit attachment of the probes to the bifunctional polymer linkers. Also provided is a method for fabricating the microarray system by first attaching the bifunctional polymer linkers to the solid support, followed by photochemical coupling of the nucleic probes to the microarray. A customizable microarray kit is provided that contains the solid support, linkers, probes, solvent mixture and instructions to use the kit.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: January 3, 2023
    Assignee: PathogenDx, Inc.
    Inventors: Michael Edward Hogan, Melissa Rose May, Frederick Henry Eggers
  • Patent number: 11535883
    Abstract: Provided herein are methods for preparing a sequencing library that includes nucleic acids from a plurality of single cells. In one embodiment, the sequencing library includes whole genome nucleic acids from the plurality of single cells. In one embodiment, the method includes generating nucleosome-depleted nuclei by chemical treatment while maintaining integrity of the nuclei. Also provided herein are compositions, such as compositions that include chemically treated nucleosome-depleted isolated nuclei.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: December 27, 2022
    Assignees: Illumina, Inc., Oregon Health & Science University
    Inventors: Andrew C. Adey, Sarah A. Vitak, Frank J. Steemers
  • Patent number: 11512307
    Abstract: Provided herein is a 3-dimensional lattice microarray system for DNA sequence detection and analysis. The system has a plurality of bifunctional polymer linkers, on one end of which are attached nucleic acid probes where each have a sequence complementary to signature nucleotide sequences in pathogens, plants or animals. The other end of the bifunctional polymer linker is attached to a solid support by non-covalent or covalent means. Each of the nucleic acid probes have terminal thymidine bases at the 5? and 3? ends that permit attachment of the probes to the bifunctional polymer linkers. Also provided is a customizable microarray kit is provided that contains the solid support, linkers, probes, solvent mixture and instructions to use the kit.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: November 29, 2022
    Assignee: PathogenDX Inc
    Inventors: Michael Edward Hogan, Melissa Rose May, Frederick Henry Eggers
  • Patent number: 11421224
    Abstract: Provided herein is a method for manufacturing a 3-dimensional lattice microarray system for DNA sequence detection and analysis. A solid support is contacted with a formulation containing a plurality of nucleic acid probes, a plurality of bifunctional polymer liners and a solvent mixture of water and a water-miscible liquid. In a first attachment reaction the bifunctional polymer linkers are attached to the solid support and the water is evaporated. In a second attachment reaction the nucleic acid probes are attached to the bifunctional polymer linker.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: August 23, 2022
    Assignee: PathogenDx, Inc.
    Inventors: Michael Edward Hogan, Melissa Rose May, Frederick Henry Eggers
  • Patent number: 11365439
    Abstract: The present invention relates to a method for the sensitive identification of high-affinity complexes made of two ligands (2, 3, 4, 5, 6, 7) and one receptor (1). A large number of different ligands (2, 3, 4, 5, 6, 7) of a chemical library are hereby contacted with at least one receptor (1) in a solution. The ligands of the library have a single-strand DNA (8, 9) or RNA with a base length of 2 to 10 bases or alternatively more than 10 bases. In addition, the solution is incubated for a specific period of time and complexes made of two ligands (2, 3, 4, 5, 6, 7) and one receptor (1) are identified.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: June 21, 2022
    Assignee: DYNABIND GMBH
    Inventors: Francesco Reddavide, Helena De Andrade, Weilin Lin, Yixin Zhang
  • Patent number: 10984891
    Abstract: A method to detect chromatin-interacting RNAs in any given state of a cell or tissue by examining global RNA interactions with DNA by deep sequencing. A method to generate a global view of chromatin-RNA interactome by mapping the binding locations on the genome of each detected chromatin interacting RNA.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: April 20, 2021
    Assignee: The Regents of the University of California
    Inventors: Xiang-Dong Fu, Bing Zhou, Xiao Li